The primary goal of Morphology Support is to make available to the investigators of individual projects the
expertise, facilities, techniques and technical support required for morphologic, immunolocalization and gene
expression studies of cultured cells and animal and human tissues at both the light and electron microscopic
level. The Core supervisor. Dr. Milstone, is an American Board of Pathology certified anatomic pathologist and
molecular experimental pathologist with a high level of training and expertise. He will provide consultation to
investigators within the Program on interpreting histopathologic changes and identifying optimal procedures for
selecting and preparing cells and tissues of experimental animals for morphologic studies.
During the renewal period the Program will continue to expand utilization of in vivo and in vitro model systems
and reagents, many developed previously within this Program or to be developed in the renewal period, to
investigate molecular regulation and consequences of endothelial-dependent physiologic and pathophysiologic
processes. Many of these experimental systems test the effects of under- or over-expressing critical adhesion,
activation and/or interaction molecules or cytokines in othenwise "normal" tissues and in models of acute and
chronic inflammation and tissue injury. Interpreting these experimental results requires describing reliably the
morphologic changes, including assessing the degree and nature of leukocyte influx and resultant tissue injury,
and immunocytochemical localization of the molecules in question. An important function of Morphology
Support will therefore be providing consistent, high quality histology and sensitive methods for
immunocytochemical localization. Program studies of intracellular communication events and cell biology will
require expanded ultrastructural analysis by electron microscopy and perhaps immunoelectronmicroscopy.
Over several Project periods Morphology Support has developed considerable experience in these techniques.
The Core benefits from dedicated and well-trained technical personnel who have performed such analyses for
up to twenty years in support ofthe Projects of this Program. They understand the various techniques required,
the needs of individual investigators and many of the scientific issues particular to individual projects.
Morphology Support has developed protocols that optimize sensitivity and specificity of immunocytochemical
localization, as evidenced by numerous publications emanating from this Program during several previous
Program periods. Examples are titration of monoclonal antibodies to allow detecting increased or decreased
abundance of a molecule which is present in the basal state (Coxon, A et al., 2001, Delfs, M W et al., 2001,
Milstone, D S et al., 2000, Milstone, D S et al., 2000), adaptation of monoclonal antibodies generated against
molecules in one experimental species to use in a different species (Milstone, D S et al., 2001), simultaneous
double staining with two monoclonal antibodies to distinguish two different protein epitopes in a single tissue
section, and immunolocalization in organ culture.
Morphology Support has also successfully developed RNA in situ hybridization that requires additional
expertise in handling target specimens and molecularly cloned nucleic acid probes to prevent degradation by
RNAses present in target cells and tissues, and by exogenous contaminant RNAses. Extensive expertise by
Dr. Milstone in preparing specimens and probes for specific detection of small quantities of mRNA in complex
mixtures has supported success of this approach. Colleagues with experience in this technique are also
available within the Departments of Pathology of Brigham and Women's Hospital and Harvard Medical School,
if needed.
These techniques carefully developed, validated and performed by Morphology Support personnel will provide
to Program Investigators morphologic and immunohistochemical preparations appropriate for image analysis.
Dr. Lichtman in Project 2 has successfully accomplished this in the past using preparations from Morphology
Support. Personnel in Core C: Physiological and Molecular Imaging Support of this Program, supervised by Dr.
Tanya Mayadas will perform these analyses in the renewal period. The technical expertise of both Cores will
thus synergize to advance the scientific goals ofthe Program and its individual components
No Sub Projects information available for 2P01HL036028-24A1 5611
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01HL036028-24A1 5611
Patents
No Patents information available for 2P01HL036028-24A1 5611
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01HL036028-24A1 5611
Clinical Studies
No Clinical Studies information available for 2P01HL036028-24A1 5611
News and More
Related News Releases
No news release information available for 2P01HL036028-24A1 5611
History
No Historical information available for 2P01HL036028-24A1 5611
Similar Projects
No Similar Projects information available for 2P01HL036028-24A1 5611